The global 3D printed implants market size was valued at US$ YY billion in 2020 and is estimated to reach US$ YY billion by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).
Implantable medical devices printed in 3D. Implantable medical devices made from 3D printing are used in numerous sections of the human body. Vascular stents, heart valve prostheses, orthopaedic implants, and artificial joint prostheses are examples of common items.
The global 3D printed implants market is driven by many factors, such as technological advancement and increased use of 3D printed implants in surgical procedures.
Download Sample Brochure @ https://www.datamintelligence.com/download-sample/3d-printed-implants-market
The technological advancement in this market is estimated to drive the global 3D printed implants market
3D printing technology, because of its advantages in high accuracy, complex structure, and high material usage, has become widely used in the field of implantable medical devices in recent decades. Patient-specific anatomical level products with great flexibility and resolution in microstructures are possible with three-dimensional (3D) printing. 3D printing has become a leading Orthopaedic and pharmaceutical manufacturing technology, with cost-effective manufacturing for high productivity. It is apt for a wide range of applications, including tissue engineering models, anatomical models, pharmacological design and validation models, medical apparatus and instruments. Today, 3D printing provides clinically viable medical items and platforms ideal for new research domains such as tissue and organ printing.
For example, on February 17, 2021, the design and print complicated implants for domestic and international markets, the Apollo Hospitals Group has partnered with Anatomiz3D Medtech Pvt Ltd. To begin, 3D-printing facilities for 3D printed implants will be established in several Apollo Hospitals, allowing clinicians to visualise and manufacture implants for difficult patients. In 2021, VESTAKEEP Care M40 3DF, a novel 3D-printable PEEK (polyetheretherketone) biomaterial created by Evonik Industries AG for medical applications requiring up to 30 days of body contact. Extrusion-based 3D printing processes like fused filament fabrication and fused deposition modelling can prepare the high-performance polymer.
By Implantation Technology
- Electron beam melting technology
- Laser Beam Melting
- Droplet Deposition
- Laminated Deposition
Major key players in the global 3D printed implants market are 3D Systems Corporations, Stratasys Ltd, Arcam AB, EnvisionTEC, SLM Solutions Group AG, Renishaw, Materialize N. V., BioBots, Andreas Stihl AG & Co. KG, Aspect Biosystems, Formlabs, Medprin, Stratasys, Organovo, Rokit, Cyfuse Biomedical and LimaCorporate S.p.A., (Lima).
DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision-making in designing disruptive solutions.
Name: Sai Kiran
Company: DataM Intelligence
Contact No: +1 8774414866
Email us: email@example.com